Brazilian Randomized Study - Impact of MRI for Breast Cancer
NCT ID: NCT02798796
Last Updated: 2016-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
372 participants
INTERVENTIONAL
2014-11-30
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contrast-enhanced MR Imaging as a Breast Cancer Screening in Women at Intermediate Risk
NCT02210546
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer
NCT01805076
Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
NCT02956473
The Impact of Preoperative Breast MRI in Patients With Breast Cancer Selected for Breast Conserving Surgery
NCT01391806
New Mammographic Techniques Versus MRI in Assessment of Breast Lesions
NCT06089148
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MRI Group
MRI Group - all patients will be submitted to clinical examination, mammography and / or ultrasound, and breast MRI
MRI
All patients will be submitted to MRI
Control Group
Control group - all patients will be submitted to clinical examination, mammography and / or ultrasound of the breasts.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
All patients will be submitted to MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 years with breast cancer
* Clinical stages I, II and III candidates for conservative surgery
Exclusion Criteria
* Claustrophobia
* Impossibility to stay in the prone position for more than an hour
* History of allergic reaction to the paramagnetic contrast
* History of chronic kidney disease on dialysis
* Personal history of breast cancer treated surgically in the last 12 months.
* Pregnancy or breastfeeding past 6 months
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruna Salani Mota, Recruiting
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade de São Paulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
974.504
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.